DIA BSWG KOL Lecture Series, L13

Event Date:

09/20/2019

Description:

Title: Why Bayes for Clinical Trials?

Speaker: Prof. Frank E Harrell

Abstract: This presentation covers the limitations of frequentist inference for answering clinical questions and generating evidence for efficacy. Key to understanding efficacy is understanding conditional probability and its relation to information flow. What type I error really controls is discussed, and it is argued that it is not regulator’s regret. The frequentist and Bayesian approaches for stating statistical results for efficacy assessment are contrasted, and a high-level view of the Bayesian approach is given. A key point is the actionability of the statistical results. Some of the advantages of the Bayesian approach are cataloged, with emphasis on forward-information-flow probabilities that instantly define their own error probabilities. Multiplicity issues are discussed, and a simple simulation study is used to demonstrate the lack of multiplicity issues in the Bayesian context even with infinitely many data looks. Some practical guidance for choosing prior distributions is given. Finally, some examples of joint Bayesian inference for multiple endpoints are given.

Slides can be accessed at http://www.bayesianscientific.org/kol-lecture-series/
or http://hbiostat.org/doc/bayes/why.pdf

Please click the link below to join the webinar:
https://diaglobal.zoom.us/j/170061680

Or iPhone one-tap :
US: +16468769923,,170061680# or +16699006833,,170061680#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 646 876 9923 or +1 669 900 6833 or 855 880 1246 (Toll Free) or 877 853 5257 (Toll Free)
Webinar ID: 170 061 680
International numbers available: https://zoom.us/u/acdf7TLZqx

Resources:

Starting Time:

11:00 am

Ending Time:

1:00 pm